133 related articles for article (PubMed ID: 6306919)
21. The use of a monoclonal antibody and of DNA recombinant technology for the localization of a poliovirus neutralization epitope in viral capsid polypeptide VP1.
Bruneau P; van der Werf S; Wychowski C; Siffert O; Girard M
Dev Biol Stand; 1984; 57():177-85. PubMed ID: 6084609
[TBL] [Abstract][Full Text] [Related]
22. Strain differentiation of polioviruses with monoclonal antibodies.
Osterhaus AD; van Wezel AL; Stegmann AJ; van Asten JA; Hazendonk AG
Dev Biol Stand; 1984; 57():135-9. PubMed ID: 6098494
[TBL] [Abstract][Full Text] [Related]
23. Monoclonal antibodies reveal in blocking reactions the antigenicity and antibody response of poliovirus.
Uhlig H; Rutter G; Dernick R
Dev Biol Stand; 1984; 57():187-91. PubMed ID: 6084610
[TBL] [Abstract][Full Text] [Related]
24. Use of monoclonal antibodies prepared with Sabin vaccine viruses for the characterization of poliovirus strains isolated in Canada.
Wachmann B; Henning D; Armstrong R; Boucher DW; Contreras G; Furesz J
Dev Biol Stand; 1984; 57():141-9. PubMed ID: 6084605
[TBL] [Abstract][Full Text] [Related]
25. Reactivity of anti-peptide and anti-poliovirus type 3 monoclonal antibodies with synthetic peptides.
Ferguson M; Reed SE; Minor PD
J Gen Virol; 1986 Nov; 67 ( Pt 11)():2527-31. PubMed ID: 2431104
[TBL] [Abstract][Full Text] [Related]
26. Antigenic analysis of poliovirus type 3 using monoclonal antibodies.
Ferguson M; Minor PD; Magrath DI; Schild GC
Dev Biol Stand; 1984; 57():151-5. PubMed ID: 6098495
[TBL] [Abstract][Full Text] [Related]
27. Characterization of human monoclonal antibodies that neutralize multiple poliovirus serotypes.
Puligedda RD; Kouiavskaia D; Al-Saleem FH; Kattala CD; Nabi U; Yaqoob H; Bhagavathula VS; Sharma R; Chumakov K; Dessain SK
Vaccine; 2017 Oct; 35(41):5455-5462. PubMed ID: 28343771
[TBL] [Abstract][Full Text] [Related]
28. [A monoclonal antibody panel for the intratypic differentiation of type-2 polioviruses].
Shyrobokov VP; Nikolaienko IV; Kopanytsia LV; Solohub VK; Ivanova OIe
Mikrobiol Z; 1997; 59(6):27-36. PubMed ID: 9511373
[TBL] [Abstract][Full Text] [Related]
29. Principal and subsidiary antigenic sites of VP1 involved in the neutralization of poliovirus type 3.
Minor PD; Evans DM; Ferguson M; Schild GC; Westrop G; Almond JW
J Gen Virol; 1985 May; 66 ( Pt 5)():1159-65. PubMed ID: 2582084
[TBL] [Abstract][Full Text] [Related]
30. [Monoclonal antibodies used to differentiate between poliovirus types 1 and 3].
Shirobokov VP; Kopanitsa LV; Nikolaenko IV; Lipatnikova KI; Sologub VK
Mikrobiol Z; 2001; 63(6):42-52. PubMed ID: 11944335
[TBL] [Abstract][Full Text] [Related]
31. Stabilization by host cell components and Mg2+ of the neutralization epitopes of poliovirus.
Rombaut B; Vrijsen R; Boeyé A
J Gen Virol; 1985 Feb; 66 ( Pt 2)():303-7. PubMed ID: 2578552
[TBL] [Abstract][Full Text] [Related]
32. Antigenic structure of polioviruses of serotypes 1, 2 and 3.
Minor PD; Ferguson M; Evans DM; Almond JW; Icenogle JP
J Gen Virol; 1986 Jul; 67 ( Pt 7)():1283-91. PubMed ID: 2425046
[TBL] [Abstract][Full Text] [Related]
33. Postabsorption neutralization of poliovirus.
Vrijsen R; Mosser A; Boeyé A
J Virol; 1993 Jun; 67(6):3126-33. PubMed ID: 8388493
[TBL] [Abstract][Full Text] [Related]
34. Conjugation of enzymes to anti-poliovirus globulin: effect of enzyme molecular weight on virus neutralization capacity.
Herrmann JE; Morse SA
Immunochemistry; 1974 Feb; 11(2):79-82. PubMed ID: 4362769
[No Abstract] [Full Text] [Related]
35. Mechanisms of neutralization of animal viruses.
Dimmock NJ
J Gen Virol; 1984 Jun; 65 ( Pt 6)():1015-22. PubMed ID: 6202836
[No Abstract] [Full Text] [Related]
36. Poliovirus mutants resistant to neutralization with soluble cell receptors.
Kaplan G; Peters D; Racaniello VR
Science; 1990 Dec; 250(4987):1596-9. PubMed ID: 2177226
[TBL] [Abstract][Full Text] [Related]
37. Antigenic sites of poliovirus type 3 eliciting IgA monoclonal antibodies in orally immunized mice.
Buttinelli G; Ruggeri FM; Marturano J; Novello F; Donati V; Fiore L
Virology; 2001 Mar; 281(2):265-71. PubMed ID: 11277698
[TBL] [Abstract][Full Text] [Related]
38. Studies of the antigenic variation in poliovirus type 1. Selection and analysis of variant strains with monoclonal antibodies by neutralization.
Thibodeau L; Lacroix M; Lecomte J; Fauvel M
Dev Biol Stand; 1984; 57():157-63. PubMed ID: 6084606
[TBL] [Abstract][Full Text] [Related]
39. Analysis of poliovirus antibody complexes by density gradient centrifugation.
Kawanishi M; Ozaki Y
Arch Virol; 1978; 57(2):189-94. PubMed ID: 208491
[TBL] [Abstract][Full Text] [Related]
40. Antigenic modification of attenuated Sabin type 1 poliovirus by in vitro passages at supraoptimal temperatures.
Crainic R; Blondel B; Candréa A; Dufraisse G; Horaud F
Dev Biol Stand; 1985; 60():343-7. PubMed ID: 2995173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
